Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avraam Avramidis

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Hormones (Athens, Greece)|August 21, 2007
Thyroid nodules - stepwise diagnosis and managementStergios A Polyzos, Marina Kita, Avraam Avramidis
Endocrine Journal|April 2, 2008
Sustained clinical inactivity and stabilization of GH/IGF-1 levels in an acromegalic patient after discontinuation of somatostatin analogue treatmentAvraam Avramidis, Stergios A Polyzos, Zoe Efstathiadou, et al.
Hormones (Athens, Greece)|August 29, 2007
Cushing's syndrome in pregnancy: report of a case and review of the literatureMarina Kita, Maria Sakalidou, Athanasios Saratzis, et al.
Hormones (Athens, Greece)|August 29, 2007
Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseasesAthanasios D Anastasilakis, Dimitrios G Goulis, Marina Kita, et al.
Clinical Endocrinology|October 17, 2009
The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosisAthanasios D Anastasilakis, Stergios A Polyzos, Avraam Avramidis, et al.
Journal of Bone and Mineral Metabolism|November 4, 2008
Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of boneAvraam Avramidis, Stergios A Polyzos, Efstratios Moralidis, et al.
European Journal of Endocrinology|February 27, 2008
Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-kappaB ligand levels in women with established osteoporosis treated with teriparatideAthanasios D Anastasilakis, Dimirtios G Goulis, Stergios A Polyzos, et al.
Clinical Endocrinology|July 16, 2008
No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trialAthanasios D Anastasilakis, Dimirtios G Goulis, Stergios A Polyzos, et al.
Endocrine Journal|June 4, 2008
Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosisAthanasios D Anastasilakis, Stergios A Polyzos, Dimitrios G Goulis, et al.
Journal of Cancer Research and Clinical Oncology|March 11, 2008
Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodulesStergios A Polyzos, Marina Kita, Zoe Efstathiadou, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Hormones (Athens, Greece)|August 21, 2007
Thyroid nodules - stepwise diagnosis and managementStergios A Polyzos, Marina Kita, Avraam Avramidis
Endocrine Journal|April 2, 2008
Sustained clinical inactivity and stabilization of GH/IGF-1 levels in an acromegalic patient after discontinuation of somatostatin analogue treatmentAvraam Avramidis, Stergios A Polyzos, Zoe Efstathiadou, et al.
Hormones (Athens, Greece)|August 29, 2007
Cushing's syndrome in pregnancy: report of a case and review of the literatureMarina Kita, Maria Sakalidou, Athanasios Saratzis, et al.
Hormones (Athens, Greece)|August 29, 2007
Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseasesAthanasios D Anastasilakis, Dimitrios G Goulis, Marina Kita, et al.
Clinical Endocrinology|October 17, 2009
The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosisAthanasios D Anastasilakis, Stergios A Polyzos, Avraam Avramidis, et al.
Journal of Bone and Mineral Metabolism|November 4, 2008
Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of boneAvraam Avramidis, Stergios A Polyzos, Efstratios Moralidis, et al.
European Journal of Endocrinology|February 27, 2008
Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-kappaB ligand levels in women with established osteoporosis treated with teriparatideAthanasios D Anastasilakis, Dimirtios G Goulis, Stergios A Polyzos, et al.
Clinical Endocrinology|July 16, 2008
No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trialAthanasios D Anastasilakis, Dimirtios G Goulis, Stergios A Polyzos, et al.
Endocrine Journal|June 4, 2008
Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosisAthanasios D Anastasilakis, Stergios A Polyzos, Dimitrios G Goulis, et al.
Journal of Cancer Research and Clinical Oncology|March 11, 2008
Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodulesStergios A Polyzos, Marina Kita, Zoe Efstathiadou, et al.
Pageof 2